Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) FCF Margin (2024)

Zentalis Pharmaceuticals has reported FCF Margin over the past 1 years, most recently at 147.78% for Q4 2024.

  • For Q4 2024, FCF Margin changed N/A year-over-year to 147.78%; the TTM value through Sep 2025 reached 498.82%, down 7439.0%, while the annual FY2024 figure was 253.74%, N/A changed from the prior year.
  • FCF Margin for Q4 2024 was 147.78% at Zentalis Pharmaceuticals, down from 128.24% in the prior quarter.
  • Over five years, FCF Margin peaked at 128.24% in Q1 2024 and troughed at 147.78% in Q4 2024.